Cargando…
Emerging immunotherapies for metastasis
Major advances in cancer immunotherapy have dramatically expanded the potential to manipulate immune cells in cancer patients with metastatic disease to counteract cancer spread and extend patient lifespan. One of the most successful types of immunotherapy is the immune checkpoint inhibitors, such a...
Autores principales: | Edwards, Sarah C., Hoevenaar, Wilma H. M., Coffelt, Seth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782509/ https://www.ncbi.nlm.nih.gov/pubmed/33262520 http://dx.doi.org/10.1038/s41416-020-01160-5 |
Ejemplares similares
-
PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A–producing γδ T cells
por: Edwards, Sarah C., et al.
Publicado: (2022) -
Immunotherapy: an emerging modality to checkmate brain metastasis
por: Ahmad, Aatiya, et al.
Publicado: (2023) -
Microfluidic technologies for immunotherapy studies on solid tumours
por: Paterson, K., et al.
Publicado: (2021) -
Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis
por: Yu, Xianzhe, et al.
Publicado: (2020) -
Toll-Like Receptor 3 and Suppressor of Cytokine Signaling Proteins Regulate CXCR4 and CXCR7 Expression in Bone Marrow-Derived Human Multipotent Stromal Cells
por: Tomchuck, Suzanne L., et al.
Publicado: (2012)